Ali health integrates tmall health food to save the market by "blue hat"

On May 19, Alibaba Health announced that it had signed a share subscription agreement with Alibaba group, and Alibaba group injected the online business of "blue hat" health food, a tmall platform worth HK $3.8 billion, into Alibaba health After the completion of the transaction, Alibaba Group's shareholding in Alibaba health will rise from about 37.9% to about 45.8%, and its voting rights will rise from about 54% to about 59.8% Ali health believes that the acquisition of the target business can bring a wider range of e-commerce businesses into the online community of medical and health care so as to enrich the ecosystem, and form an organic complementarity with the three business sectors of the company's medical e-commerce business, intelligent medical service and product traceability platform service, on the other hand, it can obtain more stable and sustainable income growth A senior e-commerce personage pointed out to the 21st century economic reporter that Alibaba health relies on Alibaba group and has natural resource advantages The growth of health care product market has been relatively stable in recent years But as a listed company, the move still needs to be approved by relevant regulators However, the capital market gave a positive response to Ali health's asset injection, which ended up 11.14% on May 19 There's a long way to go According to Alibaba health's announcement, as of March 31, 2017, more than 950 businesses in the injection business sold "blue hat" (health food registered or filed with the State Food and drug administration, with the special logo of "sky blue hat shaped mark") health food on tmall pharmaceutical platform, with more than 11.81 million active buyers and "blue hat" health food annually The turnover of goods business is about 2.772 billion yuan After the completion of the transaction, alihealth will obtain the business contract relationship of the health food merchants on tmall pharmaceutical platform, provide them with a series of value-added services including settlement, brand marketing, technical support, and collect commissions According to Alibaba financial report, the commission income of health care products business for tmall platform in 2017 amounted to 62.27 million yuan It is understood that the asset injection plan has been prepared for a long time As early as April 2016, Alibaba Health announced that it is actively exploring with Alibaba group the possibility of introducing Alibaba Group's health food, dietary nutrition supplement and traditional nutrition business into Alibaba health On October 9, 2016, Ali health and tmall medical center jointly launched the "nourishing China" brand plan, and cooperated with local governments, brand enterprises and industry associations to label high-quality tonics At the same time, alihealth has also established a "nourishing China traceability system" to realize the traceability of related tonics "one product, one code" with the help of its "code on trust" platform Kang Kai, director of Ali health and general manager of tmall's medical and health business department, disclosed to the 21st century economic reporter that tmall's Medical Center will make corresponding adjustments according to the business development and develop in depth on the basis of tmall's sales platform model, including not only drugs but also health products and pharmacist consultation On March 14, 2017, alihealth again announced that it would continue to actively seek to acquire the online business of tmall health food The signing of the share subscription agreement is exactly the concrete result of more than one year's discussion Ali health related people told 21st century economic news that "blue hat" health food is the sales category with a large share of tmall pharmaceutical platform, and there is still a huge growth space in the future The blue book on the industry development of China Pharmaceutical Materials Association 2016 released at the beginning of this year disclosed that the share of medical and health care categories in the consumption of pharmaceutical e-commerce rose from 76.9% to 82.8% in 2016, and maintained steady growth in the past three years Supplement e-commerce revenue In the past year, the launch of the HK $3.8 billion "blue hat" business acquisition is undoubtedly good for Ali's healthy development in the general trend At the beginning of 2016, Ali health encountered a "crisis", and the electronic regulatory code that contributed most of its profits was stopped by the State Food and drug administration However, the acquisition of tmall medical center was frustrated by policy and capital issues The industry was once worried about its revenue source In May 2016, the B2C third-party platform pilot expired and suspended operation, and the e-commerce platform including tmall global medicine center stopped the drug online transaction function on August 1, 2016, which to some extent impacted the sales of the platform and businesses Ali health began to search for ways to "crack" On August 17, 2016, alihealth announced that it would complete the acquisition of all the equity of Guangzhou 5000 year pharmaceutical chain Co., Ltd on August 16, and Guangzhou 5000 year pharmaceutical became a wholly-owned subsidiary of alihealth However, the move also raised questions for a time Ali health spent a huge amount of money to buy a company with a Book loss, aiming to hold the certificate C of Internet drug trade service qualification issued by Guangzhou food and drug administration, which has the e-commerce business of medicine for individual consumers when engaging in online pharmacies This may form a competitive relationship with platform businesses in the future In fact, Alibaba was promoting the incorporation of tmall global medical center into Alibaba health long before the e-regulatory code incident broke out However, due to regulatory policy restrictions and other reasons, it has been delayed to land On September 12, 2016, alihealth held a special general meeting of shareholders, which approved the signing of outsourcing value-added service agreement between alihealth and tmall, that is, alihealth will provide a full range of outsourcing and value-added services for tmall, assist tmall in developing its medical e-commerce business and collect fees Ali health has gained the opportunity based on the high-quality resources of tmall Medical Museum This time, the asset injection of tmall platform "blue hat" has made Ali healthy step forward to the construction of the whole industry ecosystem According to the future layout displayed on alihealth's official website, alihealth will build an industry wide ecosystem including medical services, medical e-commerce, personal health management and health insurance with the help of Internet and big data technology A senior e-commerce person pointed out to the 21st century economic reporter that Ali health relies on Alibaba group and has natural resource advantages The growth of health care product market is relatively stable in recent years At the same time, the change of health care product from filing system to registration system is also good for the development of health care product industry, which will also be good for the future performance growth of Ali health "As a listed company, this move still needs to be approved by relevant regulators What will happen in this process is still unknown Previously, the incorporation of tmall into Alibaba health was affected by many factors, and the final plan was changed to the operation form of exclusive agent of tmall health " Said the senior person New retail direction is becoming clear Although Alibaba health's asset injection has just started, and its future progress is unpredictable at present, there is a clear direction, that is, "new retail" in Alibaba is the general trend of future business development, and the field of medicine, health and food is no exception On the morning of May 17, Alibaba health released a notice to disclose the results of fiscal year 2017 In the fiscal year ended March 31, 2017, Ali's health revenue was 475 million yuan, an increase of 739.4% year on year Behind the increase of revenue more than 7 times, the new retail mode path of Omni channel and omni link is gradually clear Ali Health said in the financial report that it hopes to use the Internet to build a drug circulation and sales system throughout the entire industrial chain, improve the efficiency of the supply chain of medical and health products, and let all parties involved in the market and consumers benefit from it 21st century economic report (May 22, 2017)